GI
AMED

Gradient Investments’s Amedisys AMED Stock Holding History

Gradient Investments’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-188
Closed -$17.3K – 335
2024
Q2 		$17.3K Buy
+188
New +$17.4K ﹤0.01% 662
2022
Q4 		– Sell
-17
Closed -$2K – 1507
2022
Q3 		$2K Buy
+17
New +$2.03K ﹤0.01% 1116
2021
Q4 		– Sell
-2
Closed – – 1219
2021
Q3 		$0 Sell
2
-24
-92% -$4.99K ﹤0.01% 1136
2021
Q2 		$6K Sell
26
-33,641
-100% -$8.83M ﹤0.01% 838
2021
Q1 		$8.91M Buy
33,667
+15,227
+83% +$4.29M 0.29% 105
2020
Q4 		$4.36M Sell
18,440
-261
-1% -$66.9K 0.19% 116
2020
Q3 		$4.42M Sell
18,701
-2,938
-14% -$668K 0.19% 116
2020
Q2 		$4.3M Sell
21,639
-210
-1% -$39.2K 0.2% 111
2020
Q1 		$4.01M Buy
21,849
+2,993
+16% +$532K 0.22% 97
2019
Q4 		$3.15M Buy
+18,856
New +$2.8M 0.14% 111

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Gradient Investments's AMED Position: Q3 2024 in Review

Gradient Investments sold out of Amedisys (AMED) in Q3 2024, closing a stake of 188 shares — an estimated $17.3K sold.

Gradient Investments first reported a position in AMED in Q4 2019 and held it in 10 quarters. The position peaked at $8.91M in Q1 2021. 285 funds tracked by Wall St. Rank hold AMED as of Q3 2024.

  • Gradient Investments reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
  • Gradient Investments sold 188 Amedisys shares in Q3 2024, an estimated $17.3K.
  • Gradient Investments first reported a position in Amedisys in Q4 2019 and held it in 10 quarters.
  • Gradient Investments's Amedisys position peaked at $8.91M in Q1 2021.
  • 285 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.

Based on Gradient Investments's 13F filing for Q3 2024, filed 15 Oct 2024.